Target intelligence / Profile preview

RNA, U6 small nuclear 131, pseudogene (RNU6-131P)

Target
RNU6-131P
Molecular classification
Other (pseudogene; non-coding RNA-derived sequence)
01

Overview

RNU6-131P is a **pseudogene**, meaning it is a genomic DNA sequence similar to the functional U6 small nuclear RNA (snRNA) genes but is typically non-functional or not expressed as a mature RNA product. The functional **U6 small nuclear RNA** is a critical non-coding RNA component of the spliceosome, where it plays a central role in the excision of introns from pre-mRNA during RNA splicing in eukaryotic nuclei[1][2][3]. Functional U6 snRNA forms extensive secondary structures and interacts with other small nuclear RNAs and proteins to facilitate spliceosome assembly and catalysis of splicing[1][2][3]. However, RNU6-131P, as a pseudogene, does not encode an active snRNA and does not have a defined biological function or recognized disease association. **Clarification of status**: - The designation *pseudogene* means **RNU6-131P is not a therapeutic target**, not a functional receptor, enzyme, transporter, transcription factor, or any druggable biomolecule. - Its primary relevance is as a remnant of evolutionary gene duplication or retroposition, and pseudogene copies of U6 are common in mammalian genomes[2]. - No drugs, disease roles, or biomarker information are associated with RNU6-131P.

Other names
RNU6-131PRNA, U6 small nuclear 131 pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 131, pseudogene (RNU6-131P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 131, pseudogene (RNU6-131P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call